Cheol-Joo Chae

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The existence of beta-amyloid [Aβ] peptides in the brain has been regarded as the most archetypal biomarker of Alzheimer's disease [AD]. Recently, an early clinical diagnosis has been considered a great importance in identifying people who are at high risk of AD. However, no microscale electronic sensing devices for the detection of Aβ peptides have been(More)
  • 1